Plain-English translation of NCT06197581 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Radiation therapy is an important part of breast cancer treatment, and newer medications like capecitabine, CDK4/6 inhibitors, HER2 inhibitors, PARP inhibitors, and immune checkpoint inhibitors have improved outcomes for many patients. This trial is testing whether it is safe to give radiation therapy and one of these newer medications at the same time, rather than waiting until radiation is finished.
Many breast cancer patients need both radiation therapy and one of these newer medications, but doctors aren't sure whether the medication should be paused during radiation or continued at the same time. This trial will help doctors understand whether combining them is safe and which patients can benefit from this approach.
You likely qualify if…
You likely don't qualify if…
You will receive radiation therapy to your breast or chest wall while also taking one of the newer breast cancer medications at the same time—they are given together rather than one after the other. The study team will carefully monitor you for any side effects or complications from the combination treatment. You'll have regular follow-up appointments to check how well you're tolerating the combined therapy.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China